Company Analysis

AngioDynamics, Inc. (ANGO)

Nasdaq: ANGO · Surgical & Medical Instruments & Apparatus · Latham, NY · filing with the SEC since 2004
Grade5.4
◀ Past 5.5● Present 5.6▶ Future 5.0
1 est.

Who runs AngioDynamics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Honroth Eric
President and CEO. First filing Nov 2026, latest Nov 4, 2026, 0 filings in all.
Officers reporting now
7
of 14 people with a filing in the last fifteen months
Directors reporting now
7
28 people on the record since 2006
Officerssales are open-market, Nov 4, 2025 to Nov 4, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Honroth EricPresident and CEONov 2026Nov 4, 2026none
Trowbridge Stephen AEVP and CFONov 2014Oct 30, 20262 · $300,000
Nighan Warren JrSVP Quality and RegulatoryDec 2021Jul 31, 20261 · $300,000
Clemmer James CPresident and CEOApr 2016Jul 24, 2026none
Campbell Chad ThomasSVP/GM, Vascular AccessMay 2017Jul 24, 2026none
Piccinini LauraSVP InternationalJul 2021Jul 24, 2026none
Weiss Lawrence TSVP, Chief Legal OfficerDec 2024Jul 22, 2026none
Directorssales are open-market, Nov 4, 2025 to Nov 4, 2026
NameRoleFirst filingLatest filingSales, 12 months
Auen Eileen O'SheadirectorNov 2016Jul 22, 2026none
Burgess LorindadirectorJul 2023Jul 22, 2026none
Donnelly Howard WdirectorMar 2006Jul 22, 2026none
Johnson WesleydirectorFeb 2007Jul 22, 2026none
Licitra Karen AdirectorJul 2019Jul 22, 2026none
Reed Jan SterndirectorNov 2016Jul 22, 2026none
Tarnoff Michael EdirectorJul 2020Jul 22, 2026none
Earlier names on the record18, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ANGO · research, not advice